Top 100 2025
Company
Bottneuro AG
Incorporated
January 2021
Headquarter
Basel
Support
Medtech 3D Printing Digital Health Medical devices Medtech Neurology Patient monitoring Wearable technologies

Personalized brain stimulation to treat Alzheimer’s at home.

Bottneuro is revolutionizing Alzheimer's care with Miamind®, a personalized, non-invasive neurostimulation device for home use. Using MRI-based, 3D-printed caps, it delivers targeted transcranial electrical stimulation (tES) at gamma frequencies shown to improve cognition, reduce pTau levels, and slow disease progression. Registered in Switzerland and the UK as a custom-made device, Miamind® is already in use at several Swiss clinics. We aim to expand into Germany and the UK and are preparing for FDA/CE approval to scale globally.

Company News

Find here the latest news about the company.

Company Awards